Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS MedisurgiBOM:540468 79 ROC (Joel Greenblatt) % is 2.38% as of Mar. 2026, which is 54% below its 10-year median of 5.18. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.50 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 840 Medical Devices & Instruments companies, KMS Medisurgi ranks better than 52.62% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. KMS Medisurgi's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.38%.
The historical rank and industry rank for KMS Medisurgi's ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:540468'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.72 Med: 5.18 Max: 12.53
Current: 5.87
During the past 13 years, KMS Medisurgi's highest ROC (Joel Greenblatt) % was 12.53%. The lowest was 2.72%. And the median was 5.18%.
BOM:540468's ROC (Joel Greenblatt) % is ranked better than 52.62% of 840
companies
in the Medical Devices & Instruments industry
Industry Median: 4.145
vs BOM:540468: 5.87
KMS Medisurgi's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 14.40% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
KMS Medisurgi ROC (Joel Greenblatt) % Related Terms
KMS Medisurgi ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540468 vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 2.38% mean?
KMS Medisurgi (BOM:540468) has a ROC (Joel Greenblatt) % of 2.38% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on KMS Medisurgi and its competitors. This is 54% below median its historical median of 5.18. Over the past decade, KMS Medisurgi's ROC (Joel Greenblatt) % has ranged from 2.72 to 12.53. According to the industry distribution chart, KMS Medisurgi ranks #398 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 47.4%.
Is KMS Medisurgi's ROC (Joel Greenblatt) % too high?
KMS Medisurgi's current ROC (Joel Greenblatt) % of 2.38% is 54% below median its 10-year median of 5.18. Over the past 10 years, this metric has ranged from a low of 2.72 to a high of 12.53. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.15. KMS Medisurgi's value of 2.38% is 42.6% below this industry median. Based on the distribution chart, KMS Medisurgi ranks #398 out of 840 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KMS Medisurgi has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KMS Medisurgi ranks #398 out of 840 companies for ROC (Joel Greenblatt) %. This puts KMS Medisurgi in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 4.15. KMS Medisurgi's value of 2.38% is 42.6% below this benchmark. Historically, KMS Medisurgi's own ROC (Joel Greenblatt) % has ranged from 2.72 to 12.53 over the past decade. While the company's 10-year median is 5.18 vs. the industry median of 4.15, KMS Medisurgi has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.15, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current ROC (Joel Greenblatt) % of 2.38% is 42.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current ROC (Joel Greenblatt) % is 2.38%, which is 54% below median its own 10-year median of 5.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
Based on GuruFocus' analysis, KMS Medisurgi (BOM:540468) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹111.50, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current ROC (Joel Greenblatt) % is 2.38%, which is 54% below median its 10-year median of 5.18 and 42.6% below the Medical Devices & Instruments industry median of 4.15. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current ROC (Joel Greenblatt) % is 2.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.50.
GuruFocus considers KMS Medisurgi to be Modestly Overvalued.
Key valuation signals for BOM:540468:
ROC (Joel Greenblatt) %: 2.38% (54% below median its 10-year median of 5.18)
GF Value™: ₹111.50 vs. price of ₹132.80 (19.1% above fair value)
Industry Position: 42.6% below the Medical Devices & Instruments median (#398 of 840)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
